카테터 집락화가 없는 지속성 캔디다혈증의 위험인자와 예후|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Background: Candidemia is one of the most common causes of nosocomial bloodstream infection, and increases the morbidity and mortality rate of seriously ill patients. We evaluated the risk factors and outcomes associated with persistent candidemia without catheter colonization (non-catheter related candidemia) and compared them with those of non-persistent candidemia.
Materials and Methods: A retrospective case-control study was performed to identify risk factors for, and outcomes of, persistent candidemia. All adults who experienced candidemia in a university-affiliated hospital in Korea between January 2005 and December 2009 were included.
Patients with catheter colonization were excluded. Persistent candidemia was defined as the occurrence of candidemia in a patient receiving at least 3 days of systemic antifungal agents prior to the second positive blood culture.
Results: Of 605 adult patients with candidemia, 104 (17.2%) patients had persistent candidemia and 23 (3.8%) patients were free of catheter colonization. There were no statistically significant differences in baseline characteristics between patients with persistent and non-persistent candidemia. In univariate analysis, less use of metronidazole, glycopeptide, fluoroquinolone, and aminoglycoside, and presence of Candida parapsilosis were significantly associated with persistent candidemia.
In multivariate analysis, less use of metronidazole was an independent factor associated with persistent candidemia. The candidemia related mortality was insignificantly (P =0.094) higher in persistent candidemia than non-persistent candidemia.
Conclusions: Persistent candidemia can occur without catheterization. Patterns of antibiotic use could be associated with the occurrence of persistent candidemia,and prognosis of persistent candidemia seems to be worse than non-persistent candidemia. Further studies for persistent candidemia should be performed.

번역하기

참고문헌 (Reference)

1 김의종, "전국병원감염감시체계 중환자실 부문 결과 보고: 2008년 7월부터 2009년 6월까지 1년간의 결과와 3년간 전국 중환자실 병원감염발생률의 분석" 대한병원감염관리학회 15 (15): 14-25, 2010

2 Nguyen MH, "Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study" 155 : 2429-2435, 1995

3 Lee I, "Risk factors for fluconazole-resistant Candida glabrata bloodstream infections" 169 : 379-383, 2009

4 Nucci M, "Risk factors for death in patients with candidemia" 19 : 846-850, 1998

5 Nucci M, "Risk factors for breakthrough candidemia" 21 : 209-211, 2002

6 Uzun O, "Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia" 32 : 1713-1717, 2001

7 Pasqualotto AC, "Risk factors and outcome for nosocomial breakthrough candidaemia" 52 : 216-222, 2006

8 Chung JW, "Risk factors and outcome for breakthrough candidaemia in patients with cancer" 49 : 114-118, 2006

9 Kontoyiannis DP, "Risk Factors for Candida tropicalis fungemia in patients with cancer" 33 : 1676-1681, 2001

10 Lin MY, "Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study" 49 : 4555-4560, 2005